BTIG analyst Sean Lavin maintained a Buy rating on Establishment Labs Holdings Inc (ESTA) yesterday and set a price target of $40. The company’s shares closed last Monday at $22.54.
According to TipRanks.com, Lavin is a 4-star analyst with an average return of 2.9% and a 52.9% success rate. Lavin covers the Healthcare sector, focusing on stocks such as Helius Medical Technologies, Tactile Systems Technology, and Boston Scientific Corp.
Establishment Labs Holdings Inc has an analyst consensus of Strong Buy, with a price target consensus of $37.40.
See today’s analyst top recommended stocks >>
Based on Establishment Labs Holdings Inc’s latest earnings release for the quarter ending March 31, the company reported a quarterly GAAP net loss of $10.78 million. In comparison, last year the company had a GAAP net loss of $5.36 million.
Based on the recent corporate insider activity of 7 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of ESTA in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Establishment Labs Holdings, Inc. engages in the design, development, manufacture, and marketing of silicone breast implants. It offers its products under Motiva Implants brand. The company was founded by Juan Jose Chacon-Quiros in 2013 and is headquartered in Alajuela, Costa Rica.
